TRJ.AU Trajan Group Holdings Ltd
- Market cap
- AUD 38.2M
- P/E
- -
- P/B
- 0.39x
- ROE
- -0.6%
- Dividend yield
- -
- Fundamental score
- 1.4/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is TRJ.AU undervalued?
Graham numberThe Graham number of Trajan Group Holdings Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Trajan Group Holdings Ltd fundamental analysis
7 of 21 checks passedROE 0/2
Low return on equity (-0.6%), below 10%.
ROA 1/1
Return on assets (-0.3%) is above the industry median (-35.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (86.1%) is above the industry median (24.9%).
Revenue Growth 0/2
Revenue shrank 0.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (58.9%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Cash covers 4.0 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.4x) is below the industry median (4.0x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Trajan Group Holdings Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Trajan Group Holdings Ltd
Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including gas purifiers and filters, inlet liners, syringes, CB emitters, and tubing products, as well as columns, connections, septa, and inlet liners. It also provides sampling products comprising septa, caps, liners, well pl…
Full company profileTrajan Group Holdings Ltd financial statements
Trajan Group Holdings Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 54.3M | 57.2M | 67.8M | 71.9M | 76.6M | 108M | 162M | 155M | 166M | 161M |
| Gross Profit | 24.3M | 7.50M | 7.69M | 5.86M | 28.5M | 42.6M | 22.9M | 59.8M | 63.5M | 16.9M |
| Operating Income | 243K | 2.44M | 2.96M | 1.43M | 2.08M | 2.91M | 10.2M | 3.39M | 3.49M | 4.24M |
| EBITDA | 1.09M | 3.16M | 4.45M | 3.26M | 3.46M | 5.14M | 14.2M | -20.4M | 12.8M | 13.0M |
| Net Income | 691K | 1.45M | 2.14M | 2.62M | 1.88M | 1.70M | 1.89M | -25.3M | -4.46M | -623K |
| EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | -0.17 | -0.03 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 30.7M | 33.0M | 41.4M | 44.4M | 99.4M | 207M | 229M | 188M | 196M | 184M |
| Total Liabilities | 19.3M | 19.4M | 25.4M | 26.6M | 33.3M | 90.3M | 99.5M | 85.1M | 90.0M | 85.5M |
| Shareholders' Equity | 11.4M | 13.6M | 16.0M | 17.7M | 66.1M | 117M | 130M | 103M | 106M | 98.5M |
| Cash & Short-term Investments | 2.34M | 3.55M | 3.98M | 4.79M | 51.7M | 13.2M | 11.0M | 11.2M | 11.9M | 12.6M |
| Total Debt | 9.18M | 9.12M | 9.51M | 15.0M | 17.0M | 66.2M | 61.3M | 56.2M | 55.5M | 58.0M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 2.11M | 1.69M | 2.84M | 1.76M | 9.86M | 2.74M | 9.55M | 9.48M | 10.8M | 242K |
| Capital Expenditure | 1.80M | 618K | 2.68M | 797K | 1.11M | 3.42M | 8.55M | 3.04M | 4.09M | 3.42M |
| Free Cash Flow | 310K | 1.08M | 164K | 964K | -1.11M | -3.42M | 998K | 6.44M | 6.74M | -3.18M |
| Ratios | ||||||||||
| ROE | 6.1% | 10.6% | 13.4% | 14.8% | 2.8% | 1.5% | 1.5% | -24.6% | -4.2% | -0.6% |
| ROA | 2.3% | 4.4% | 5.2% | 5.9% | 1.9% | 0.8% | 0.8% | -13.5% | -2.3% | -0.3% |
| Net Profit Margin | 1.3% | 2.5% | 3.2% | 3.6% | 2.5% | 1.6% | 1.2% | -16.3% | -2.7% | -0.4% |
| Debt to Equity | 0.81x | 0.67x | 0.59x | 0.84x | 0.26x | 0.57x | 0.47x | 0.55x | 0.53x | 0.59x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Trajan Group Holdings Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | AUD 181K | 0.00 | 9.6% |
| 2022 | AUD 49.2M | 0.36 | 2,888.2% |
| 2021 | AUD 3.35M | 0.03 | 178.2% |
| 2020 | AUD 3.35M | 0.03 | 127.9% |
| 2019 | AUD 3.35M | 0.03 | 156.4% |
| 2018 | AUD 3.35M | 0.03 | 231.4% |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Trajan Group Holdings Ltd
- Insiders 59.54%
- Institutions 21.73%
- Public & others 18.73%
- Shares outstanding 153M
- Free float 62.1M
Trajan Group Holdings Ltd company profile
- Company name
- Trajan Group Holdings Ltd
- Ticker
- TRJ.AU
- ISIN
- AU0000150526
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 620
- Fiscal year end
- June
- Address
- 7 Argent Place, Ringwood, VIC, Australia, 3134
- Phone
- 61 3 9837 4200
- Website
- trajanscimed.com
About Trajan Group Holdings Ltd
Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including gas purifiers and filters, inlet liners, syringes, CB emitters, and tubing products, as well as columns, connections, septa, and inlet liners. It also provides sampling products comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro-sampling tools. In addition, the company provides pathology products, such as NBF containers; adhesive and frosted microscope slides; coverslips; microtome blades; biopsy pads; tissue marking dyes and sets; microscope slide storage trays/mailers; microscope slide and cassette storage boxes; and histology wax plus. Further, it offers analytical, automation, life sciences, sampling literature support products. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.
Trajan Group Holdings Ltd management
8- Mr. Stephen TomisichFounder, CEO, MD & Executive Director
- Mr. Simon BillinghamInterim CFO & Interim Joint Company Secretary
- Mr. Robert LyonExecutive Director, Head of Corporate Development & General Counsel
- Mr. Nigel GilliganChief Operations Officer
- Dr. Andrew Arthur Gooley FCA, MAICD, Ph.D.Chief Scientific Officer
- Ms. Marie KrsticHead of Corporate Communications & Investor Relations
- Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSPJoint Company Secretary · born 1964
- Ms. Rebecca Jayne Wilson B.A.Investor Relations Advisor · born 1973